The theoretical and realistic analysis of medical insuranc e payment stan dard for pharmaceuti-cal in China / 中国卫生政策研究

ABSTRACT

It is an important countermeasure in the world to establish the medical insurance payment standard (reference price)to control the growth of pharmaceutical costs.Medical insurance payment standards for pharmaceu-ticals affect patients,behavior and pharmaceutical pricing through enhancing competition for pharmaceutical demand and patients,choice.After the liberalization of government pricing in China,it was also needed to establish the price formation mechanism to adapt to the development of pharmaceutical market.To establish the medical insurance pay-ment standards,one should know more about the development of China,s pharmaceutical policy and the current situa-tion and clarify the specific mechanism of controlling expenses.To achieve a sustainable availability of drugs, the control of costs and policy incentives,it is crucial to identify the problems in practice,pay close attention to the es-tablishment of pharmaco-economic evaluation system,drug classification management,the medical insurance payment and compensation levels,a reasonable allocation of compensation balance and so on.